Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Inhibitors of kinases claimed by Schering AG

July 15, 2004

Novel CDK inhibitors from BMS show in vivo anticancer activity

July 15, 2004

Oxford GlycoSciences claims antiangiogenic agents

July 14, 2004

Vertex claims protein kinase inhibitors

July 14, 2004

Fast track status for pixantrone in aggressive NHL

July 14, 2004

Adherex Technologies updates status of two key programs

July 14, 2004

Cytorex Biosciences completes cytotoxicity testing with Cytoreg

July 14, 2004

Inhibitors of receptor tyrosine kinases claimed by Array BioPharma

July 13, 2004

Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth

July 13, 2004

Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma

July 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...